(Q42024592)

English

New alpha 2-adrenergic blocker (DG-5128) improves insulin secretion and in vivo glucose disposal in NIDDM patients

scientific article published on October 1986

Statements

New alpha 2-adrenergic blocker (DG-5128) improves insulin secretion and in vivo glucose disposal in NIDDM patients (English)
1 October 1986
1085-1089

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit